Zhang Jian, Li Junfeng, Chen Yu, Ding Mei, Duan Zhongping
Difficult & Complicated Liver diseases and Artificial Liver Center, Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.
Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing, People's Republic of China.
Diabetes Metab Syndr Obes. 2021 Jun 9;14:2573-2580. doi: 10.2147/DMSO.S309641. eCollection 2021.
Critical illness-related corticosteroid insufficiency (CIRCI) is known to be a common complication in patients with acute-on-chronic liver failure (ACLF). However, factors that predict the survival rate of ACLF patients remain unclear. The present study aims to determine the prognostic factors that impinge on the survival rate of ACLF patients.
A total of 90 patients with ACLF at different stages, with or without CIRCI, were prospectively evaluated.
Various clinical factors were found to be significantly different among patients at early, mid and late stages of ACLF, as well as between the same population of patients with and without CIRCI. Specifically, patients at later stages of ACLF and patients with CIRCI had significantly higher Child-Turcotte-Pugh (CTP), Model for End-Stage Liver Disease (MELD) and ACLF Research Consortium (AARC)-ACLF scores. CIRCI was observed in 20% of the enrolled patients (18 out of 90). In addition, the 90-day mortality rate was higher in mid- and late-stage ACLF patients, as well as patients with CIRCI.
ACLF stage and CIRCI predict early mortality in patients with ACLF and could be actively monitored in these patients for prioritized liver transplantation.
危重症相关皮质类固醇激素缺乏(CIRCI)是急性慢性肝衰竭(ACLF)患者常见的并发症。然而,预测ACLF患者生存率的因素仍不清楚。本研究旨在确定影响ACLF患者生存率的预后因素。
前瞻性评估了90例不同阶段的ACLF患者,包括有或无CIRCI的患者。
发现ACLF早期、中期和晚期患者之间以及有和无CIRCI的同一患者群体之间的各种临床因素存在显著差异。具体而言,ACLF晚期患者和CIRCI患者的Child-Turcotte-Pugh(CTP)、终末期肝病模型(MELD)和ACLF研究联盟(AARC)-ACLF评分显著更高。在纳入的患者中有20%(90例中的18例)观察到CIRCI。此外,ACLF中期和晚期患者以及CIRCI患者的90天死亡率更高。
ACLF分期和CIRCI可预测ACLF患者的早期死亡率,对这些患者可进行积极监测,以便优先进行肝移植。